Publication | Open Access

Capecitabine plus oxaliplatin versus gemcitabine plus oxaliplatin as first-line therapy for advanced biliary tract cancers: a multicenter, open-label, randomized, phase III, noninferiority trial

First-line TherapyGastrointestinal OncologyMedicineBiliary CancerPhase IiiMolecular OncologyCancer TreatmentNoninferiority TrialOncologyRadiation OncologyCancer ResearchRadiologyHealth Sciences